Skip to content

Clinical trials

Phase 2 Carcinoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 2 Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20082
20094
20111
20141
20191
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Steba Biotech S.A.2
AbbVie (prior sponsor, Abbott)1
AstraZeneca1
Imperial College London1
Iovance Biotherapeutics, Inc.1
Pfizer1
Revolution Medicines, Inc.1
Royal Marsden NHS Foundation Trust1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma16
Neoplasms10
Neoplasms by Site5
Adenocarcinoma3
Lung Diseases3
Bronchial Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Fallopian Tube Neoplasms2
Genital Neoplasms, Male2
Lung Neoplasms2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.